[This Week's IPO] Demand Forecast and Subscription Schedule for the Second Week of July

[Asia Economy Reporter Jang Hyowon] In the second week of this month (July), Sungil Hightech, ICH, April Bio, and Susan Industry will conduct demand forecasting for institutional investors. Lunit is preparing for a general subscription.

◆Sungil Hightech= Established in 2000, Sungil Hightech is a secondary battery recycling specialist company that extracts precious metals from secondary batteries included in products such as electric vehicles, mobile phones, laptops, energy storage systems (ESS), and power tools. It is the only company in Korea that possesses an integrated secondary battery recycling process, producing cobalt, nickel, lithium, and more.

The total number of shares offered is 2.67 million, with a desired offering price band of 40,700 to 47,500 KRW per share. Demand forecasting will be conducted on the 11th and 12th to finalize the offering price, followed by a general subscription on the 18th and 19th. The listing is scheduled for the end of this month, with KB Securities and Daishin Securities as the lead underwriters and Samsung Securities participating as the underwriting company.

◆ICH= This company holds the ‘room temperature press patterning process’ for antenna manufacturing. It implements precise antenna circuits solely by press methods at room temperature without applying heat. The three main products driving ICH’s performance are adhesive tapes for IT devices, electromagnetic shielding gaskets, and film-type thin antennas (MFA, Metal Foil Antenna).

The total number of shares offered is 1.18 million, with a proposed offering price band of 34,000 to 44,000 KRW, amounting to a total offering size of approximately 40.1 billion to 51.9 billion KRW. Demand forecasting will be conducted on the 13th and 14th to finalize the offering price, followed by subscription on the 19th and 20th, with plans to list on KOSDAQ within this month. Samsung Securities is the lead underwriter.

◆April Bio= Established in 2013, April Bio is a protein (antibody) therapeutic development company targeting autoimmune diseases, inflammatory diseases, and cancer by utilizing the platform technology ‘SAFA (Anti-Serum Albumin Fab)’ that extends the half-life (the time it takes for the drug concentration to reduce to half from its peak) of drugs, and the antibody library technology (HuDVFab, Human naive Fab antibody library) that discovers antibodies matching target antigens.

The total number of shares offered is 1.62 million, with an expected offering price of 20,000 to 23,000 KRW, totaling approximately 32.4 billion to 37.3 billion KRW. Demand forecasting will be conducted over two days on the 13th and 14th, followed by subscription on the 19th and 20th, with plans to enter the KOSDAQ market on the 28th of this month. NH Investment & Securities is the lead underwriter.

◆Susan Industry= Established in 1983, Susan Industry provides comprehensive maintenance services for major nuclear, thermal, and renewable power plants, enhancing equipment operation rates and preventing unexpected shutdowns. According to last year’s consolidated financials, sales proportions were 48.7% nuclear, 31.1% thermal, 10.8% renewable, and 9.4% others.

The total number of shares offered is 5.715 million, with a desired offering price band of 35,000 to 43,100 KRW per share. Demand forecasting will be conducted on the 14th and 15th to finalize the offering price, followed by a general subscription over two days on the 20th and 21st. The listing is scheduled for the end of this month, with Samsung Securities as the lead underwriter.

◆Lunit= Lunit’s expected offering price per share is 44,000 to 49,000 KRW. Demand forecasting for institutional investors was conducted until the 8th, and general subscription will be held on the 12th and 13th, with plans to list within this month. The total number of shares offered is 1.2143 million, aiming to raise approximately 53.4 billion KRW.

Founded in 2013, Lunit is a medical artificial intelligence (AI) company whose flagship products include the AI imaging analysis solution for cancer diagnosis, 'Lunit INSIGHT,' and the AI biomarker platform for cancer treatment, 'Lunit SCOPE.'

This content was produced with the assistance of AI translation services.